ACRS Aclaris Therapeutics Inc

Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology.

$17.95  +0.04 (0.22%)
As of 06/22/2021 15:59:51 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/07/2015
Outstanding shares:  52,107,355
Average volume:  903,952
Market cap:   $953,043,523
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00461U105
ISIN:        US00461U1051
Sedol:      BYV2W40
Valuation   (See tab for details)
PE ratio:   -14.54
PB ratio:   8.31
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy